Tim McInerney
Director
Tim McInerney brings over 30 years of experience as a pharmaceutical executive and healthcare investment banker and analyst with positions in industry and a number of Wall Street firms. Following positions at Bristol, Myers Squibb, Bear Stearns, Shearson Lehman Brothers and Ladenburg Thalmann, Tim oversaw the overall distribution of Paramount Capital Group’s private equity product and was directly responsible for over $1B in capital raised for both startups and private placement investments.
In the early stage financings of Cougar Biotech (acquired by J&J), Kite Pharma, Velcera (acquired by Perrigo) and Ziopharm Oncology, Tim played a significant role. He has served on numerous public and private boards including, chairman of InSite Vision (acquired by Sun Pharmaceuticals) and Edgemont Pharmaceuticals (acquired by Alvogen, Inc.). He also served on the board of Emisphere Technologies and led the Special Committee in negotiating the sale of the company to Novo Nordisk for $1.8 billion in December of 2020. In addition, Tim is a co-founding investor and board member of Corino Therapeutics.
Mr. McInerney received his BS in Pharmacy from St. John’s University and also completed a post-graduate residency in drug information systems at the New York University Medical Center.
